Fig. 2From: Chronic inflammatory demyelinating polyneuropathy (CIDP): change of serum IgG dimer levels during treatment with intravenous immunoglobulinsAnti-GQ1b antibody ELISA of samples from MFS patients. Anti-GQ1b-antibodies are detectable in monomeric IgG fractions pre- and post-IVIg treatment and in dimeric IgG fraction post-IVIg treatmentBack to article page